SCHEMBL26847480

SCHEMBL26847480

N#Cc1c(Cc2cccs2)nc(SCc2ncn[nH]2)[nH]c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRNP P04156 5/20 0.46
▸ RXFP1 Q9HBX9 5/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ NPSR1 Q6W5P4 4/20 0.46
▸ POLB P06746 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ SAE1 Q9UBE0 1/20 0.46
▸ UBA2 Q9UBT2 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HPGD P15428 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ ACMSD Q8TDX5 9/20 0.42
▸ CYP2C19 P33261 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ PSMD14 O00487 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087918 0.85 MEN1 (0.47) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL24087944 0.84 ACMSD (0.51) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL24087920 0.80 KMT2A (0.55) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL26847479 0.79 NPSR1 (0.68) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL26847476 0.78 ACMSD (0.45) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL26847469 0.78 MEN1 (0.44) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL24088150 0.78 PRNP (0.44) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL24087917 0.78 ACMSD (0.45) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL24087922 0.77 RXFP1 (0.56) PRNPRXFP1MEN1KMT2ANPSR1
SCHEMBL26847482 0.77 RXFP1 (0.61) PRNPRXFP1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 PRNP 569/4885RXFP1 4311/4885MEN1 2572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback